Abstract:PURPOSE. Intravitreal injection of antiangiogenic agents is becoming a standard treatment for neovascular retinal diseases. Sustained release of therapeutics by injecting colloidal carriers is a promising approach to reduce the injection frequency, which reduces treatment burdens and the risk of complications on patients. Such sustained release often requires carriers to have micrometer-scale dimension that, however, can potentially promote glaucoma and inflammation. Small, polycationic particles can be immobilized in vitreous through multiple cooperative ionic interactions with hyaluronic acid of the vitreous interior, but such particles are generally toxic. Here, we synthesized and examined a biocompatible dextran-based nanocarrier (<50 nm in diameter) conjugated with cationic peptides containing L-arginine with minimal toxicity, aiming to provide sustained release of therapeutic drugs in vitreous.METHODS. We synthesized the nanocarriers with condensed cholesteryl dextran (CDEX) as core material. Cationic peptides containing 1 to 4 arginine groups, along with fluorescence tags, were conjugated to the CDEX surface. We monitored the carrier diffusion rate ex vivo and half-lives in vivo in rodent vitreous using fluorescence imaging. We evaluated the toxicity by histological examinations at the second, third, eighth, and thirty-sixth week.RESULTS. The diffusion rate of nanocarriers was inversely related to zeta potential values in freshly isolated vitreous humor. We observed increased half-lives in vivo with increasing zeta potential (up to 240 days). Histological examinations confirmed no adverse effects on ocular morphology and organization.CONCLUSIONS. We demonstrated the potential of L-arginine peptide-conjugated nanocarriers toward safe and sustained therapeutic release system for posterior eye diseases.

Framework Nucleic Acids as Blood-Retinal-Barrier-Penetrable Nanocarrier for Periocular Administration

Nanoparticles in the Ocular Drug Delivery

Recent Advances and Prospects for Lipid-Based Nanoparticles As Drug Carriers in the Treatment of Human Retinal Diseases

Framework Nucleic Acids Loaded with Quercetin: Protecting Retinal Neurovascular Unit via the Protein Kinase B/Heme Oxygenase-1 Pathway

Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment

Intraocular Fate of Polycaprolactone Nanoparticles Administered Via Intravitreal and Various Periocular Routes: Bioimaging of Integral Nanoparticles Using Environment-Sensitive Fluorophores

Effective Treatment of Haemophilus influenzae -Induced Bacterial Conjunctivitis by a Bioadhesive Nanoparticle Reticulate Structure

Application of organic nanocarriers for intraocular drug delivery

PLGA Nanoparticle Platform for Trans-Ocular Barrier to Enhance Drug Delivery: A Comparative Study Based on the Application of Oligosaccharides in the Outer Membrane of Carriers

Multifunctional nano-in-micro delivery systems for targeted therapy in fundus neovascularization diseases

Ocular barriers to retinal delivery of intravitreal liposomes: Impact of vitreoretinal interface

Development of Nanofibrous Ocular Insert for Retinal Delivery of Fluocinolone Acetonide

Ocular therapies with biomacromolecules: From local injection to eyedrop and emerging noninvasive delivery strategies

In-situ tear fluid dissolving nanofibers enable prolonged viscosity-enhanced dual drug delivery to the eye

Advances in the development of lipid nanoparticles for ophthalmic therapeutics

Macromolecular Platform with Super-Cation Enhanced Trans-Cornea Infiltration for Noninvasive Nitric Oxide Delivery in Ocular Therapy

A novel penetratin-modified complex for noninvasive intraocular delivery of antisense oligonucleotides.

Lipid nanoparticle technology-mediated therapeutic gene manipulation in the eyes

Sustaining Intravitreal Residence With L-Arginine Peptide-Conjugated Nanocarriers

Active Trans-Corneal Drug Delivery with Ocular Adhesive Micelles for Efficient Glaucoma Therapy.

Ocular RNA Nanomedicine: Engineered Delivery Nanoplatforms in Treating Eye Diseases